文献速递小儿神经外科与脑积水

BASICS试验对脑室腹腔分流手术的临床与卫生经济影响:英国分流登记分析

Clinical and health economic impact of the BASICS trial on ventriculoperitoneal shunt surgery: UK Shunt Registry analysis.
PubMed 文献 · J Neurosurg · 2026-01-23

该回顾性研究利用英国分流登记数据,比较BASICS试验前后首次脑室腹腔分流术中抗生素分流管的使用变化及感染翻修率。结果显示抗生素分流管使用率大幅上升,儿童和成人感染率均显著降低,每年为NHS节省约100万英镑。

要点

  • 抗生素分流管使用率从2004年儿童36.9%、成人20.5%升至2021年99.2%和96.8%。
  • 抗生素分流管感染率显著低于标准分流管:儿童5.1% vs 1.9%,成人1.5% vs 0.9%。
  • 抗生素分流管每年为NHS节省约£1,004,572(95%CI £738,496-£1,270,648)。

核心结论

  • BASICS试验后英国神经外科实践明显改变,抗生素分流管成为首选,感染减少且每年节省约100万英镑。

研究设计与样本

  • 回顾性研究,使用英国分流登记数据,比较BASICS前(2004年1月至2013年6月)与BASICS后(2018年1月至2021年12月)首次脑室腹腔分流术患者。
  • 纳入任何年龄的脑积水患者,主要结局为抗生素分流管使用百分比,次要结局为感染翻修率,并进行预算影响分析。

主要发现

  • 研究期间共12,476例患者(22%为儿童)在36个中心行首次分流置入,共1226次翻修。
  • 抗生素分流管使用率从2004年儿童36.9%、成人20.5%增至2021年儿童99.2%、成人96.8%。
  • 2018至2019年(BASICS报告年)变化最大,儿童和成人分别增加14.9%和27.2%。
  • 与标准分流管相比,抗生素分流管感染率在儿童(5.1% vs 1.9%,p < 0.001)和成人(1.5% vs 0.9%,p = 0.031)均显著降低。

关键数值与推荐

  • 抗生素分流管使用率儿童从36.9%升至99.2%,成人从20.5%升至96.8%(2004年至2021年)。
  • 感染率儿童5.1% vs 1.9%(p < 0.001),成人1.5% vs 0.9%(p = 0.031)。
  • 每年节省£1,004,572(95%CI £738,496-£1,270,648)。

临床怎么用

  • 抗生素分流管可作为首次脑室腹腔分流术的首选,以降低感染风险并节约医疗成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the clinical and health economic impact of the British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts (BASICS) trial on UK shunt surgery practice and shunt infection rates. METHODS: This retrospective study used UK Shunt Registry data to compare antibiotic and standard shunt use in patients undergoing the first insertion of a ventriculoperitoneal shunt during pre-BASICS (January 2004 to June 2013) and post-BASICS (January 2018 to December 2021) periods. Patients of any age with hydrocephalus who underwent a primary ventriculoperitoneal shunt insertion were included. The percentage of antibiotic shunts inserted was the primary outcome, and the revision rate for infection was the secondary outcome. A budget impact analysis was performed to estimate the cost savings from reduced shunt infection. RESULTS: Across the study period, 12,476 patients (22% pediatric patients) underwent primary shunt insertions with 1226 revisions across 36 centers. Antibiotic shunt use increased from 36.9% in pediatric patients and 20.5% in adults in 2004, to 99.2% in pediatric patients and 96.8% in adults in 2021. The largest change was from 2018 to 2019 (year of BASICS reporting), with a 14.9% and 27.2% increase for pediatric and adult patients, respectively. Compared with standard shunts, the infection rate for antibiotic shunts was significantly lower in both pediatric (5.1% vs 1.9%, p < 0.001) and adult (1.5% vs 0.9%, p = 0.031) patients. Antibiotic shunts saved the NHS an estimated £1,004,572 (95% CI £738,496-£1,270,648) per year. CONCLUSIONS: BASICS has been followed by evident change in UK neurosurgical practice. Antibiotic shunts are the first choice for patients, with reduced infection and cost savings of approximately £1 million per year.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bakhsh A, Fernández Méndez R, Culeddu G, et al. Clinical and health economic impact of the BASICS trial on ventriculoperitoneal shunt surgery: UK Shunt Registry analysis. J Neurosurg. 2026. PMID: 41576382. doi:10.3171/2025.8.JNS251266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。